Bausch Health Co. Inc. (BHC) and Clearside (CLSD) Announce US Launch of XIPERE Mar 28, 2022 06:59AM
Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associa Mar 28, 2022 06:59AM
Bausch + Lomb (BHC) and Clearside Biomedical Announce FDA Approval of XIPERE for Suprachoroidal Use for Treatment of Macular Edema Associated with Uveitis Oct 25, 2021 06:45AM
Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uvei Oct 25, 2021 06:45AM
Bausch Health Co. Inc. (BHC) And Clearside Biomedical (CLSD) Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) Jun 2, 2021 07:00AM
View Older Stories

Jun 2, 2021 06:59AM Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension)
Jan 20, 2019 11:15AM Presentation of Clearside Biomedical’s Extension Study of PEACHTREE for XIPERE™ Exhibits Durability Following Second Dose
Jan 20, 2019 11:15AM Presentation of Clearside Biomedical’s Extension Study of PEACHTREE for XIPERE™ Exhibits Durability Following Second Dose
Jan 2, 2019 08:00AM Clearside Biomedical to Present at the 37th Annual J.P. Morgan Healthcare Conference
Jan 2, 2019 08:00AM Clearside Biomedical to Present at the 37th Annual J.P. Morgan Healthcare Conference
Dec 19, 2018 04:05PM Clearside Biomedical (CLSD) Submits NDA for XIPERE for Treatment of Macular Edema Associated with Uveitis
Dec 19, 2018 04:05PM Clearside Biomedical Submits New Drug Application for XIPERE™ for the Treatment of Macular Edema Associated with Uveitis
Dec 19, 2018 04:05PM Clearside Biomedical Submits New Drug Application for XIPERE™ for the Treatment of Macular Edema Associated with Uveitis
Nov 8, 2018 07:00AM Clearside Biomedical Announces Third Quarter 2018 Financial Results and Provides Corporate Update
Nov 8, 2018 07:00AM Clearside Biomedical Announces Third Quarter 2018 Financial Results and Provides Corporate Update
Nov 7, 2018 04:30PM Clearside Biomedical to Participate in Stifel 2018 Healthcare Conference
Nov 7, 2018 04:30PM Clearside Biomedical to Participate in Stifel 2018 Healthcare Conference
Nov 5, 2018 04:30PM Clearside Biomedical to Report Third Quarter 2018 Financial Results on Thursday, November 8, 2018 – Conference Call to Follow
Nov 5, 2018 04:30PM Clearside Biomedical to Report Third Quarter 2018 Financial Results on Thursday, November 8, 2018 – Conference Call to Follow
Nov 5, 2018 07:08AM Clearside Biomedical (CLSD) Reports SAPPHIRE Phase 3 Study of Combination Therapy in Retinal Vein Occlusion Did Not Meet Its Primary Endpoint
Nov 5, 2018 07:00AM Clearside Biomedical Announces SAPPHIRE Phase 3 Study of Combination Therapy in Retinal Vein Occlusion Did Not Meet Its Primary Endpoint
Nov 5, 2018 07:00AM Clearside Biomedical Announces SAPPHIRE Phase 3 Study of Combination Therapy in Retinal Vein Occlusion Did Not Meet Its Primary Endpoint
Oct 29, 2018 10:27AM Clearside Biomedical (CLSD) Highlights Additional Analysis of PEACHTREE Clinical Trial Data to Support Potential of XIPERE in Treating Uveitic
Oct 29, 2018 10:25AM Presentation of Additional Analyses of Clearside’s PEACHTREE Clinical Trial Data Further Supports Potential of XIPERE™ in Treating Uveitic Macular Edema
Oct 29, 2018 10:25AM Presentation of Additional Analyses of Clearside’s PEACHTREE Clinical Trial Data Further Supports Potential of XIPERE™ in Treating Uveitic Macular Edema
Oct 25, 2018 08:00AM Clearside Biomedical Appoints Thomas A. Ciulla, M.D., MBA as Chief Medical Officer
Oct 25, 2018 08:00AM Clearside Biomedical Appoints Thomas A. Ciulla, M.D., MBA as Chief Medical Officer
Oct 22, 2018 04:30PM CLEARSIDE, XIPERE™ and PEACHTREE to be Front and Center at AAO 2018
Oct 22, 2018 04:30PM CLEARSIDE, XIPERE™ and PEACHTREE to be Front and Center at AAO 2018
Oct 19, 2018 08:00AM Clearside Biomedical Appoints Veteran Supply Chain Executive, Thomas Crawford, as Vice President, Supply Chain
Oct 19, 2018 08:00AM Clearside Biomedical Appoints Veteran Supply Chain Executive, Thomas Crawford, as Vice President, Supply Chain
Sep 26, 2018 04:32PM Clearside Biomedical (CLSD) Names Jeffrey Edwards to Board
Sep 26, 2018 04:30PM Clearside Biomedical Appoints Jeffrey Edwards to Board of Directors
Sep 26, 2018 04:30PM Clearside Biomedical Appoints Jeffrey Edwards to Board of Directors
Sep 19, 2018 05:54AM Clearside Biomedical (CLSD) Announces Positive PEACHTREE Data to be Highlighted at EURETINA 2018
Sep 18, 2018 04:30PM Positive PEACHTREE Data to be Highlighted at EURETINA 2018
Sep 18, 2018 04:30PM Positive PEACHTREE Data to be Highlighted at EURETINA 2018
Sep 13, 2018 08:00AM Data From Clearside Biomedical’s Pivotal Phase 3 PEACHTREE Clinical Trial in Macular Edema Associated with Non-Infectious Uveitis to be Presented at the Retina Society 51st Annual Scientific Meeting
Sep 13, 2018 08:00AM Data From Clearside Biomedical’s Pivotal Phase 3 PEACHTREE Clinical Trial in Macular Edema Associated with Non-Infectious Uveitis to be Presented at the Retina Society 51st Annual Scientific Meeting
Sep 12, 2018 04:30PM Clearside Biomedical Appoints Viral Kansara as Vice President, Discovery
Sep 12, 2018 04:30PM Clearside Biomedical Appoints Viral Kansara as Vice President, Discovery
Sep 11, 2018 04:30PM Clearside Biomedical Appoints Accomplished Pharmaceutical Industry Legal Executive, Leslie Zacks, as General Counsel and Chief Compliance Officer
Sep 11, 2018 04:30PM Clearside Biomedical Appoints Accomplished Pharmaceutical Industry Legal Executive, Leslie Zacks, as General Counsel and Chief Compliance Officer
Sep 10, 2018 04:30PM Clearside Biomedical to Participate in 2018 Janney Healthcare Conference
Sep 10, 2018 04:30PM Clearside Biomedical to Participate in 2018 Janney Healthcare Conference
Sep 6, 2018 04:30PM Clearside Biomedical Further Strengthens Commercial Organization With Appointment of Lester Rodríguez as Vice President, Quality
Sep 6, 2018 04:30PM Clearside Biomedical Further Strengthens Commercial Organization With Appointment of Lester Rodríguez as Vice President, Quality
Aug 9, 2018 08:00AM Clearside Biomedical to Participate in 2018 Wedbush PacGrow Healthcare Conference
Aug 9, 2018 08:00AM Clearside Biomedical to Participate in 2018 Wedbush PacGrow Healthcare Conference
Aug 8, 2018 07:00AM Clearside Biomedical Announces Second Quarter 2018 Financial Results and Provides Corporate Update
Aug 8, 2018 07:00AM Clearside Biomedical Announces Second Quarter 2018 Financial Results and Provides Corporate Update
Aug 1, 2018 08:00AM Clearside Biomedical to Report Second Quarter 2018 Financial Results on August 8, 2018 – Conference Call to Follow
Aug 1, 2018 08:00AM Clearside Biomedical to Report Second Quarter 2018 Financial Results on August 8, 2018 – Conference Call to Follow
Jul 16, 2018 04:30PM Clearside Biomedical to Present Data from its Pivotal Phase 3 (“PEACHTREE”) Trial in Macular Edema Associated with Uveitis at the 2018 American Society of Retina Specialists Annual Meeting
Jul 16, 2018 04:30PM Clearside Biomedical to Present Data from its Pivotal Phase 3 (“PEACHTREE”) Trial in Macular Edema Associated with Uveitis at the 2018 American Society of Retina Specialists Annual Meeting
View Older Stories